🔴 Vera Therapeutics is trading 4.07% down today with no company-specific catalyst identified

Vera Therapeutics is trading at $35.32 (-4.07%) with no new company-specific announcement identified for August 27, 2026.

• Recent gains followed 4.37%, 4.63%, and 4.48% advances, broader biotech strength, and expectations for Q3 ORIGIN 3 results.
• S&P 500 and Nasdaq Composite are higher, limiting a market-wide explanation; today’s decline appears stock-specific or profit-taking.
• Company press-release listings showed no newer announcement through August 26.